{"organizations": [], "uuid": "97f53cf5a3f5b8632fd670bf3426e155a960480c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180309.html", "section_title": "Archive News &amp; Video for Friday, 09 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-indias-panacea-biotec-gets-eir-fro/brief-indias-panacea-biotec-gets-eir-from-u-s-fda-for-malpur-facility-idUSFWN1QR0EB", "country": "US", "domain_rank": 408, "title": "BRIEF-India's Panacea Biotec Gets EIR From U.S. FDA For Malpur Facility‍​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-03-09T17:28:00.000+02:00", "replies_count": 0, "uuid": "97f53cf5a3f5b8632fd670bf3426e155a960480c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-indias-panacea-biotec-gets-eir-fro/brief-indias-panacea-biotec-gets-eir-from-u-s-fda-for-malpur-facility-idUSFWN1QR0EB", "ord_in_thread": 0, "title": "BRIEF-India's Panacea Biotec Gets EIR From U.S. FDA For Malpur Facility‍​", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "malpur", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biotec ltd", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 9 (Reuters) - Panacea Biotec Ltd:\n* GETS EIR FROM U.S. FDA * GETS ESTABLISHMENT INSPECTION REPORT INDICATING FORMAL CLOSURE OF INSPECTION AT PHARMACEUTICAL FORMULATION FACILITY AT MALPUR\n* CO NOW ALLOWED TO CONTINUE SUPPLY OF ALL APPROVED DRUG PRODUCTS BY U.S. FDA INTO INTER-STATE COMMERCE ‍​ Source text - bit.ly/2FDumVW Further company coverage:\n ", "external_links": ["http://bit.ly/2FDumVW", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-09T17:28:00.000+02:00", "crawled": "2018-03-10T20:06:03.008+02:00", "highlightTitle": ""}